1 / 19

Therapeutic Treatment of Resveratrol on Alzheimer’s Disease with CL2006

Sohrab Vatsia. Therapeutic Treatment of Resveratrol on Alzheimer’s Disease with CL2006. Need. Alzheimer’s Incidents in the U.S. Figure 1. Figure 2. http://www.omh.state.ny.us/omhweb/Statewideplan/2005/images/figure4.2.gif.

ardara
Download Presentation

Therapeutic Treatment of Resveratrol on Alzheimer’s Disease with CL2006

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sohrab Vatsia Therapeutic Treatment of Resveratrol on Alzheimer’s Disease with CL2006

  2. Need Alzheimer’s Incidents in the U.S. Figure 1 Figure 2 http://www.omh.state.ny.us/omhweb/Statewideplan/2005/images/figure4.2.gif http://uscnews2.usc.edu/Publication_JPGS/HSCWeekly/2003/HSCW2665p1.jpg

  3. Alzheimer’s Disease Figure 1 Figure 2 Figure 1 http://www.nia.nih.gov/NR/rdonlyres/A294D332-71A2-4866-BDD7-A0DF216DAAA4/0/Alzheimers_Disease_Unraveling_the_Mystery.pdf http://www.nia.nih.gov/NR/rdonlyres/A294D332-71A2-4866-BDD7-A0DF216DAAA4/0/Alzheimers_Disease_Unraveling_the_Mystery.pdf Figure 3 http://www.nia.nih.gov/NR/rdonlyres/A294D332-71A2-4866-BDD7-A0DF216DAAA4/0/Alzheimers_Disease_Unraveling_the_Mystery.pdf

  4. Resveratrol http://www.resveratrol.org.uk/resveratrol.gif • Rogers, Kara, ed. "Alzheimer's Disease." Encyclopedia Britannica. 15th ed. 2002. 306-07.

  5. Resveratrol’s Role http://www.chiro.org/nutrition/ABSTRACTS/Resveratrol_in_Prevention_and_Treatment.pdf

  6. CL2006 http://wormsrus.50webs.com/Nematodes/C%20elegans.JPG

  7. Literature Review • Marambaud, 2008 (Marambaud, 2008)

  8. Literature Review • Vingtdeux, 2005 (O’Neill, 2002)

  9. Literature Review • Anekonda, 2006 (Rodgers, 2006)

  10. Literature Review • Duchen, 2004 (Marambaud, 2005)

  11. Hypothesis/ Purpose • The purpose of the experiment is to analyze the therapeutic and preventative potential of Resveratrol on Alzhemier’s disease. • Alternate - with the administration of Resveratrol in the CL 2006 model, amyloid-beta production will slow, and the spread of the amyloid-beta molecules will reduce. • Null - There will be no change in amyloid beta production nor paralysis with the addition of Resveratrol.

  12. Protocols • Preparation of Bacterial Plates (Siernagle, 2009) (Yun, 2007)

  13. Protocols • Resveratrol Administration (Halliwell, 2004) • Concentration <or = to 100 micromolars (Lenker, 2001)

  14. Protocols • C. elegans synchronization • Paralyzed versus Non-Paralyzed (Cheng,2002)

  15. Protocols • Staining using Congo Red Dye-registers Amyloid Beta Plaques (Zhao, 1999)

  16. Do-Ability • This project is do-able because we have all the necessary materials in the lab • C. elgegans (both CL 2006 and wild-type) are readily available as well as their environments ie; plates, food, living conditions • Resveratrol is also readily available, it can be purchased relatively easily • Amyloid Stain is readily available • Microscope/s are available along with the prism and a Motic camera are also readily available; thus observation is do-able

  17. CL 2006 Resveratrol (Preventative) CL 2006 Resveratrol Therapeutic CL 2006 Gamma-Secretase C. Elegans Control CL 2006 Control C. Elegans adminsteredResveratrol(negative control) Stain and monitor amyloid levels, as well as monitor lifespan Treat on the onset of paralysis. Measure lifespan, stain, and measure amyloid-beta levels Monitor Life Span, Stain, and obeserve amyloid-beta levels Tested in order to make sure that the amyloid-beta is being targeted (2 or 3 trials) Treat with Resveratrol prior to paralysis. Measure Lifespan, stain,and measure amyloid-beta levels. Monitor Lifespan Record Qualitative and Quantitative Data based upon the observations, and following the protocols, (Lifespan, Amyloid-Beta Levels) Statistical Analysis by Two Way Anova followed by Scheffe Post-Hoc (p<.05)

  18. Bibliography • Bundschuh, K. "The worm in humans." 11 Nov. 2008. Biotechnology and Life Sciences in Baden-Württemberg. 6 May 2009 <http://www.bio-pro.de/magazin/wissenschaft/archiv_2008/index.html?lang=en&artikelid=/artikel/00452/index.html>. • Cheng, Louse. “Compound in Red Wine May Fight Alzeimer’s.” WebMD. 4 Nov. 2005. 15 Apr. 2009 <http://www.webmd.com/alzheimers/news/20051104/compound-in-red-wine-may-fight-alzheimer>. • Duchen, Michael R. "Roles of Mitochondria in Health and Disease." Whereas some of the genes identified in the control of longevity appear to target mitochondria or at least to alter antioxidant defenses of the cell (Duchen, 2004. 2004. Diabetes. 7 May 2009 <http://diabetes.diabetesjournals.org/cgi/content/full/53/suppl_1/S96>. • Halliwell, Barry, and John M.C. Gutteridge. Free Radicals in Biology and Medicine. 3rd ed. New York: Oxford UP, 2004. • Lagouge, Marie, Carmen Argmann, Zachary Gerhart-Hines, Hamid Meziane, Carles Lerin, Frederic Daussin, Nadia Messadeq, Jill Milne, Philip Lambert, Peter Elliott, Bernard Geny, Markku Laakso, Pere Puigserver, and Johan Auwerx. "Resveratrol Improves Mitochondrial Function and Protects Against Metabolic Disease by Activating SIRT1 and PGC-1a." Cell (2006). 20 May 2008. • Lenker, David P. Professional Guide to Diseases. 8th ed. New York: Williams & Wilkins., 2005 • Marambaud, Phillipe. Wine Compound May Help Cut Risk of Alzheimer’s Disease. 16 Nov. • 2005. 24 Apr. 2009 <http://www.sciencedaily.com/releases/2008/06/080617165716.htm>. • McKenzie, Maureen A. "Insulin Receptor-Like Protein." Patent Storm. 5 Oct. 1992. 18 Apr. 2008. • O,Neill, Bill. "In Methuselah’s Mould." Feature 2 (2004): 0014-017. PLoS Biology. <http://www.culturagalega.org/imaxes/docs/plos_lonxevidade.pdf>. • "Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease ( whether any of the Company's product ca...)." • Bio-Medicine - latest biology and medical news/technology. 26 June 2007. 29 Apr. 2009 <http://www.bio-medicine.org/medicine-technology/Resveratrol-Studies-Suggest-Broad-Implications-for-SIRT1-Activation-0Ain-Neurodegenerative-Diseases-of-Aging-Such-as-Alzheimers-Disease-189-3/>. • Rodgers, Anne B. "Alzheimer's Disease: Unraveling the Mystery." Alzheimer's Disease NIH 2005 (2003). • Rogers, Kara, ed. "Alzheimer's Disease." Encyclopedia Britannica. 15th ed. 2002. 306-07. • Society for Neuroscience. "Grape Seed Extract May Reduce Cognitive Decline Associated With Alzheimer's Disease." ScienceDaily 18 June 2008. 29 April 2009 <http://www.sciencedaily.com /releases/2008/06/080617165716.htm>. • Vingtdeux, Valérie, Ute Dreses-Werringloer, Haitian Zhao, Peter Davies, and Philippe Marambaud. "Therapeutic potential of resveratrol in Alzheimer's disease." BMC Neuroscience 9 (2008): 1-5.

More Related